Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Povidone-Iodine Rinses for COVID-19
NCT04449965Phase 1Terminated
- Sponsor
- St. Paul's Hospital
- Start
- Jan 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of povidone-iodine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by St. Paul's Hospital. Primary endpoints: Time to a negative/undetectable RT-PCR SARS-CoV-2 saliva sample at 6 weeks and SARS-CoV-2 viral load changes in the saliva at 6 weeks. Started Jan 2021; status: terminated.
02
Drugs
povidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04449965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04449965.